UK-based Allergy Therapeutics (OTCPK:AGYTF) announces the publication of positive data on its peanut allergy vaccine candidate in The Journal of Allergy and Clinical Immunology.
Results from a peanut allergy mouse model showed
that the novel virus-like particle platform used in the vaccine
candidate could treat the allergies and prevent anaphylaxis based on a
single injection.
https://seekingalpha.com/news/3535635-allergy-therapeutics-peanut-allergy-vaccine-shows-encouraging-action-in-animal-model
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.